PACB

Neutral

Pacific Biosciences (PACB) Reports Q1 EPS

Pacific Biosciences (NASDAQ:PACB) reported Q1 EPS of (12c), narrowly beating the consensus estimate of (13c), but revenue of $37.18M fell short of the...

Insider Monkey 3 weeks ago 0

Bullish

[10-Q] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Earnings Report

Pacific Biosciences of California, Inc. (PACB) reported Q1 2026 revenue of $37.2 million, flat year-over-year, with higher consumable sales offsetting...

Stock Titan 3 weeks ago 0